🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction

RecruitingNAAges 18 Years - anyAllRabin Medical Center
NCT05992363 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone stent in patients with MUO. The primary endpoint is stent failure rate. The secondary endpoints are patient comfort, quality of life and overall survival.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patient with malignant ureteral obstruction Exclusion Criteria: * ureteral obstruction of other causes * Language comprehension or other limitation in giving informed consent
💊

What it tests

  • ureteral stent\s insertion
📍

Where

2 sites
Rabin Medical Center
Petah Tikva, Israel
Sheba medical center
Ramat Gan, Israel
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy